SCREENER COMPARE ANY 2 STOCKS

EXCHANGE TRADED FUND

ARKG.L

Ark Genomic Revolution Ucits ETF AccumUSD

$9.20 ▲ 1.00%

+$0.09 TODAY

FUND FACTS

Manager ARK

Assets $85.71M

Expense ratio 0.75%

Inception Apr 12, 2024

Asset class Equity

Holdings 32

Volume 5.86K

Avg volume 36.17K

ABOUT THIS FUND

The investment objective of the Fund is to generate long term capital growth (5 years or more)

PRICE

$9.20 ▲ UP 1.00% (+$0.09)

HOLDINGS

TOP 20 OF 32 · 85.94% OF THE FUND

RANK STOCK WEIGHT SHARES VALUE

01

TWST Twist Bioscience Corporation 9.91% 0 $8.49M

02

TEM Tempus AI, Inc. 6.69% 0 $5.73M

03

CRSP CRISPR Therapeutics AG 6.07% 0 $5.2M

04

TXG 10x Genomics, Inc. 5.81% 0 $4.98M

05

ABSI Absci Corporation 5.20% 0 $4.46M

06

CDNA CareDx, Inc 5.00% 0 $4.29M

07

LLY Eli Lilly and Company 4.97% 0 $4.26M

08

ILMN Illumina, Inc. 4.68% 0 $4.01M

09

PSNL Personalis, Inc. 4.66% 0 $3.99M

10

NTRA Natera, Inc. 4.25% 0 $3.64M

11

CMPS COMPASS Pathways plc 4.06% 0 $3.48M

12

BEAM Beam Therapeutics Inc. 3.66% 0 $3.14M

13

GH Guardant Health, Inc. 3.14% 0 $2.69M

14

NRIX Nurix Therapeutics, Inc. 2.89% 0 $2.48M

15

RXRX Recursion Pharmaceuticals, Inc. 2.75% 0 $2.36M

16

BFLY Butterfly Network, Inc. 2.74% 0 $2.35M

17

NTLA Intellia Therapeutics, Inc. 2.73% 0 $2.34M

18

VCYT Veracyte, Inc. 2.45% 0 $2.1M

19

ADPT Adaptive Biotechnologies Corporation 2.17% 0 $1.86M

20

WGS GeneDx Holdings Corp. 2.11% 0 $1.81M

SECTOR HOLDINGS

TECHNOLOGY IS 100.00% OF THE FUND

Healthcare 100.00%

BY REGION

UNITED STATES IS 89.58% OF THE FUND

United States 89.58%

Switzerland 5.86%

United Kingdom 3.60%

— Other 0.95%